| Financial Year |
March 31 2023 |
| Monetary Funds |
1,542,879,350.69 |
| Held-for-trading Financial Assets |
175,770,946.42 |
| Notes Receivable |
-- |
| Accounts Receivable |
363,593,490.84 |
| Advances to Suppliers |
21,717,461.49 |
| Other Receivables |
29,437,627.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
732,434,656.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
59,116,985.24 |
| Total Current Assets |
2,924,950,518.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
244,153,562.10 |
| Investment Properties |
-- |
| Fixed Assetes |
713,579,986.58 |
| Under-construction Projects |
200,363,842.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,627,471.96 |
| R&D expenses |
-- |
| Goodwill |
17,253,892.81 |
| Long-Term Deferred and Prepaid Expenses |
18,673,820.13 |
| Deferred Income Tax Assets |
65,410,419.27 |
| Other Non-Current Assets |
13,173,579.19 |
| Sub-Total of Non-Current Assets |
1,897,953,731.17 |
| Total Assets |
4,822,904,249.86 |
| Short-Term Loans |
583,075,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
307,969,029.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,009,979.19 |
| Taxes Payable |
22,484,742.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
130,450,526.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
99,177,556.08 |
| Other Current Liabilities |
723,050.03 |
| Sub-Total of Current Liabilities |
1,210,287,779.17 |
| Long-term Loans |
158,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
77,065,065.50 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
522,598,553.96 |
| Total Liabilities |
1,732,886,333.13 |
| Paid-In Capital(Or Share Stock) |
358,489,251.00 |
| Capital Surplus |
1,825,673,689.29 |
| Surplus Reserve |
143,030,838.15 |
| LESS:Treasury Stock |
74,970,587.43 |
| Undistributed Profits |
826,718,057.93 |
| Minority Stockholder's Interest |
4,301,377.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,085,716,538.98 |
| Owner's Equity（Stockholder's Equity） |
3,090,017,916.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,822,904,249.86 |
